July 15th- Sonrotoclax Monotherapy After BTK Inhibitor Therapy in Mantle Cell Lymphoma CME Congresses . July 15th- Sonrotoclax Monotherapy After BTK Inhibitor Therapy in Mantle Cell Lymphoma July 13th- Beyond the Webinar: CAR-T Therapy in Lymphoma: Entering a New Era of Engineering and Accessibility CME Congresses . July 13th- Beyond the Webinar: CAR-T Therapy in Lymphoma: Entering a New Era of Engineering and Accessibility July 9th- Beyond the Webinar: EBV Infection After Allogeneic Stem Cell Transplantation – From Viral Monitoring to Precision Cellular Therapy CME Congresses . July 9th- Beyond the Webinar: EBV Infection After Allogeneic Stem Cell Transplantation – From Viral Monitoring to Precision Cellular Therapy July 6th- Beyond the Webinar: Fertility After CAR-T Cell Therapy: Moving Beyond Survival Toward Survivorship CME Congresses . July 6th- Beyond the Webinar: Fertility After CAR-T Cell Therapy: Moving Beyond Survival Toward Survivorship July 2nd- MajesTEC-5: Is Teclistamab Moving to the Frontline of Multiple Myeloma? CME Congresses . July 2nd- MajesTEC-5: Is Teclistamab Moving to the Frontline of Multiple Myeloma? June 25th- Beyond the webinar: VEXAS Syndrome: When Inflammation Becomes Clonal Hematology CME Congresses . June 25th- Beyond the webinar: VEXAS Syndrome: When Inflammation Becomes Clonal Hematology June 19th- Post-ASCO and EHA 2026: Multiple Myeloma at the Immunotherapy Crossroads CME Congresses . June 19th- Post-ASCO and EHA 2026: Multiple Myeloma at the Immunotherapy Crossroads June 22nd- Can an All-Oral Combination Change the Treatment Landscape of Relapsed/Refractory DLBCL? CME Congresses . June 22nd- Can an All-Oral Combination Change the Treatment Landscape of Relapsed/Refractory DLBCL? June 14th- LIVE from #EHA26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma? CME Congresses . June 14th- LIVE from #EHA26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma? June 13th- LIVE from #EHA26- MonumenTAL-3: is Talquetamab Redefining Early Relapse Myeloma? CME Congresses . June 13th- LIVE from #EHA26- MonumenTAL-3: is Talquetamab Redefining Early Relapse Myeloma? Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24
